These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3921173)

  • 1. Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalised anxiety.
    Power KG; Jerrom DW; Simpson RJ; Mitchell M
    Br Med J (Clin Res Ed); 1985 Apr; 290(6477):1246-8. PubMed ID: 3921173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial.
    Rickels K; Schweizer E; DeMartinis N; Mandos L; Mercer C
    J Clin Psychopharmacol; 1997 Aug; 17(4):272-7. PubMed ID: 9241006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study.
    Fontaine R; Beaudry P; Beauclair L; Chouinard G
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):189-97. PubMed ID: 2888159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis.
    Lapierre YD; Tremblay A; Gagnon A; Monpremier P; Berliss H; Oyewumi LK
    J Clin Psychiatry; 1982 Sep; 43(9):372-4. PubMed ID: 6126475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment.
    Fontaine R; Chouinard G; Annable L
    Am J Psychiatry; 1984 Jul; 141(7):848-52. PubMed ID: 6145363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buspirone: anxiolytic?
    Pecknold JC; Familamiri P; Chang H; Wilson R; Alarcia J; McClure DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):639-42. PubMed ID: 2868495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study.
    Winokur A; Rickels K; Greenblatt DJ; Snyder PJ; Schatz NJ
    Arch Gen Psychiatry; 1980 Jan; 37(1):101-5. PubMed ID: 6986133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks' treatment with diazepam or buspirone.
    Murphy SM; Owen R; Tyrer P
    Br J Psychiatry; 1989 Apr; 154():529-34. PubMed ID: 2686797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind study of metaclazepam versus diazepam treatment of outpatients with anxiety syndrome.
    Laakmann G; Blaschke D; Hippius H; Schewe S
    Pharmacopsychiatry; 1989 May; 22(3):120-5. PubMed ID: 2568645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.
    Jacobson AF; Goldstein BJ; Dominguez RA; Steinbook RM
    J Clin Psychiatry; 1983 Aug; 44(8):296-300. PubMed ID: 6135690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Annable L; Chouinard G; Ogilvie RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled comparison of buspirone and oxazepam in generalized anxiety.
    Ansseau M; Papart P; Gérard MA; von Frenckell R; Franck G
    Neuropsychobiology; 1990-1991; 24(2):74-8. PubMed ID: 2134114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    Maletzky BM
    J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal reaction after long-term therapeutic use of benzodiazepines.
    Busto U; Sellers EM; Naranjo CA; Cappell H; Sanchez-Craig M; Sykora K
    N Engl J Med; 1986 Oct; 315(14):854-9. PubMed ID: 3092053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in "withdrawal symptoms" following discontinuation of low-dose diazepam.
    Hayward P; Wardle J; Higgitt A; Gray J
    Psychopharmacology (Berl); 1996 Jun; 125(4):392-7. PubMed ID: 8826545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
    Noyes R; Garvey MJ; Cook B; Suelzer M
    Am J Psychiatry; 1991 Apr; 148(4):517-23. PubMed ID: 2006699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketazolam and diazepam in anxiety: a controlled study.
    Rickels K; Csanalosi I; Greisman P; Mirman MJ; Morris RJ; Weise CC; Weiss G
    J Clin Pharmacol; 1980 Oct; 20(10):581-9. PubMed ID: 6108335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal symptoms and rebound anxiety after six weeks course of diazepam.
    Oswald I
    Br Med J (Clin Res Ed); 1985 Jun; 290(6484):1827. PubMed ID: 3924275
    [No Abstract]   [Full Text] [Related]  

  • 19. Withdrawal and pseudowithdrawal from diazepam therapy.
    Winokur A; Rickels K
    J Clin Psychiatry; 1981 Nov; 42(11):442-4. PubMed ID: 7298586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term diazepam therapy and clinical outcome.
    Rickels K; Case WG; Downing RW; Winokur A
    JAMA; 1983 Aug; 250(6):767-71. PubMed ID: 6348314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.